San Jose | Nicotinamide, a form of vitamin B3, is emerging as a promising supplement for glaucoma. While it doesn’t lower eye pressure, research suggests it may protect the optic nerve by boosting cellular energy and supporting retinal ganglion cells. Early studies show safety and potential benefits, but larger clinical trials are still underway. Could this be the future of glaucoma care?